Pharmacokinetic profile of levofloxacin following once-daily 500-milligram oral or intravenous doses

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 10, 1997, Pages 2256-2260

  Chien, Shu Chean ^a   Rogge, Mark C ^a,b   Gisclon, Lee G ^a   Curtin, Chris ^a   Wong, Frank ^a   Natarajan, Jaya ^a   Williams, R Rex ^a   Fowler, Cynthia L ^a   Cheung, Wing K ^a   Chow, Andrew T ^a  

^a R W JOHNSON PHARMACEUTICAL RES I   (United States)

^b BIOGEN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEVOFLOXACIN;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG FORMULATION; DRUG UPTAKE; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0030864108     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.10.2256     Document Type: Article

References (18)

1. Chien, S. C., A. T. Chow, J. Natarajan, R. R. Williams, F. A. Wong, M. C. Rogge, and R. K. Nayak. 1997. Absence of age and gender effects on the pharmacokinetics of a single 500-milligram oral dose of levofloxacin in healthy subjects. Antimicrob. Agents Chemother. 41:1562-1565.
2. Chow, A. T., F. A. Wong, M. C. Rogge, and S. C. Flor. 1992. Pharmacokinetics of levofloxacin after 500 mg b.i.d. and 500 mg q.d. oral doses to two different groups of healthy volunteers. In Abstracts of the 4th International Symposium on New Quinolones, Munich, Germany.
3. Cunha, B. A. 1997. Intravenous-to-oral antibiotic switch therapy. Postgrad. Med. 101:111-128.
4. Fu, K. P., S. C. Lafredo, B. Foleno, D. M. Isaacson, J. F. Barrett, A. J. Tobia, and M. E. Rosenthale. 1992. In vitro and in vivo antibacterial activities of levofloxacin (l-ofloxacin), an optically active ofloxacin. Antimicrob. Agents Chemother. 36:860-866.
5. Fujimoto, T., and S. Mitsuhashi. 1990. In vitro antibacterial activity of DR-3355, the S-(-) isomer of ofloxacin. Chemotherapy (Tokyo) 36:268-276.
6. Gibaldi, M., and D. Perrier. 1982. Pharmacokinetics, 2nd ed. Marcel Dekker, Inc., New York, N.Y.
7. Goodwin, S. D., H. A. Gallis, A. T. Chow, F. A. Wong, S. C. Flor, and J. A. Bartlett. 1994. Pharmacokinetics and safety of levofloxacin in patients with human immunodeficiency virus infection. Antimicrob. Agents Chemother. 38:799-804.
8. Holland, M. L., S. C. Chien, M. L. Corrado, S. C. Flor, and M. C. Rogge. 1994. The pharmacokinetic profile of levofloxacin followng once-or twice-daily 500 mg oral administration of levofloxacin hemihydrate. In Abstracts of the 5th International Symposium on New Quinolones, Singapore.
9. Holland, M. L., S. C. Chien, M. L. Corrado, S. C. Flor, and M. C. Rogge. 1994. The pharmacokinetic profile of intravenous levofloxacin following once-or twice-daily 500 mg administration. In Abstracts of the 5th International Symposium on New Quinolones, Singapore.
10. Hooper, D. C., and J. S. Wolfson. 1991. Fluoroquinolone antimicrobial agents. N. Engl. J. Med. 324:384-394.
11. R. W. Johnson Pharmaceutical Research Institute. Analytical method of levofloxacin in human serum and urine by high performance liquid chromatography (HPLC). Data on file. R. W. Johnson, Pharmaceutical Research Institute, Raritan, N.J.
12. Page, E. B. 1963. Ordered hypotheses for multiple treatments: a significance test for linear ranks. J. Am. Statist. Assoc. 58:216-230.
13. SAS Company. 1990. SAS/STAT user's guide, vol. 2, version 6, 4th ed. SAS Company, Cary, N.C.
14. Schuirmann, D. J. 1987. A comparison of the two one-sided tests procedure and power approach for assessing the equivalence of average bioavailability. J. Pharmacokinet. Biopharm. 15:657-680.
15. Smith, I. L., and J. J. Schentag. 1984. Noncompartmental determination of the steady-state volume of distribution during multiple dosing. J. Pharm. Sci. 73:281-282.
16. Une, T., T. Fujimoto, K. Sato, and Y. Osada. 1988. In vitro activity of DR-3355, an optically active ofloxacin. Antimicrob. Agents Chemother. 32: 1336-1340.
17. von Rosenstiel, N., and A. Dieter. 1994. Quinolone antibacterials: an update of their pharmacology and therapeutic use. Drugs 47:872-901.
18. Wong, F. A., S. J. Juzwin, and S. C. Flor. 1997. Rapid stereospecific high-performance liquid chromatographic determination of levofloxacin in human plasma and urine. J. Pharm. Biomed. Anal. 15:765-771.